Lido Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Sell |
2,598
-9
| -0.3% | -$746 | ﹤0.01% | 1341 |
|
|
2025
Q1 | $211K | Sell |
2,607
-404
| -13% | -$32.8K | ﹤0.01% | 1266 |
|
|
2024
Q4 | $271K | Buy |
3,011
+35
| +1% | +$3.15K | ﹤0.01% | 1153 |
|
|
2024
Q3 | $294K | Buy |
2,976
+199
| +7% | +$19.7K | ﹤0.01% | 1052 |
|
|
2024
Q2 | $257K | Sell |
2,777
-63
| -2% | -$5.84K | ﹤0.01% | 1068 |
|
|
2024
Q1 | $270K | Buy |
2,840
+409
| +17% | +$38.8K | ﹤0.01% | 1036 |
|
|
2023
Q4 | $217K | Buy |
+2,431
| New | +$217K | ﹤0.01% | 1062 |
|
|
2023
Q3 | – | Sell |
-2,815
| Closed | -$234K | – | 1131 |
|
|
2023
Q2 | $234K | Buy |
+2,815
| New | +$234K | ﹤0.01% | 938 |
|
|
2023
Q1 | – | Sell |
-3,116
| Closed | -$259K | – | 1064 |
|
|
2022
Q4 | $259K | Sell |
3,116
-170
| -5% | -$14.1K | ﹤0.01% | 746 |
|
|
2022
Q3 | $260K | Buy |
3,286
+321
| +11% | +$25.4K | ﹤0.01% | 713 |
|
|
2022
Q2 | $220K | Sell |
2,965
-799
| -21% | -$59.3K | ﹤0.01% | 736 |
|
|
2022
Q1 | $338K | Sell |
3,764
-213
| -5% | -$19.1K | ﹤0.01% | 678 |
|
|
2021
Q4 | $446K | Sell |
3,977
-25
| -0.6% | -$2.8K | ﹤0.01% | 573 |
|
|
2021
Q3 | $502K | Sell |
4,002
-513
| -11% | -$64.3K | 0.01% | 520 |
|
|
2021
Q2 | $611K | Buy |
4,515
+248
| +6% | +$33.6K | 0.01% | 420 |
|
|
2021
Q1 | $579K | Buy |
4,267
+782
| +22% | +$106K | 0.01% | 413 |
|
|
2020
Q4 | $490K | Buy |
3,485
+146
| +4% | +$20.5K | 0.01% | 425 |
|
|
2020
Q3 | $372K | Buy |
3,339
+7
| +0.2% | +$780 | 0.01% | 387 |
|
|
2020
Q2 | $373K | Buy |
3,332
+35
| +1% | +$3.92K | 0.01% | 351 |
|
|
2020
Q1 | $255K | Buy |
3,297
+2
| +0.1% | +$155 | 0.01% | 403 |
|
|
2019
Q4 | $313K | Buy |
+3,295
| New | +$313K | 0.01% | 433 |
|